1261583

Summit Biosciences Inc. — FEI 3007577023

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 21, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Lexington, KY (United States)

Citations

IDCFRDescription
22921FDCA 582(b)(4)Systems in place to comply with verification requirements
358321 CFR 211.110(a)Written in-process control procedures